Treatment of axial spondyloarthritis patients with biologic disease-modifying anti-rheumatic drugs in 2022 - data from the Romanian Registry of Rheumatic Diseases

Objective. The objective of this cross-sectional study was to analyze data available in the Romanian Registry of Rheumatic Diseases (RRBR) in 2022 for axial spondyloarthritis (axSpA) patients treated with biologic disease modifying anti-rheumatic drugs (bDMARDs). Methods. From the RRBR electronic da...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Laura Muntean, Razvan Ionescu, Corina Mogosan, Maria-Magdalena Tamas, Claudiu C. Popescu, Elena Rezus, Razvan-Constantin Ionitescu, Ana Maria Ramazan, Andrei Eugen Martin, Catalin Codreanu
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Amaltea Medical Publishing House 2023-12-01
Edice:	Romanian Journal of Rheumatology
Témata:	axial spondyloarthritis biologics romanian registry of rheumatic diseases
On-line přístup:	https://rjr.com.ro/articles/2023.4/RJR_2023_4_Art-04.pdf
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!